Implantica publishes Interim Report January – June 2024 (Q2)
VADUZ, Liechtenstein, Aug. 21, 2024 /PRNewswire/ — RefluxStop⢠is on a wave of success – carried by a multitude of published studies with excellent outcomes from leading European Reflux-centers Significant events in the second quarter of 2024 Module 1 review of Premarket Approval (PMA)…
Composition of Kamux’s Shareholders’ Nomination Board
Kamux Corporation, Stock Exchange Release, 21.8.2024 at 9:15 HÃMEENLINNA, Finland, Aug. 21, 2024 /PRNewswire/ — The shareholders of Kamux Corporation have nominated their representatives for the Shareholders’ Nomination Board for the term 2024-2025. The Shareholders’ Nomination Board…
Interim report- SciBase
STOCKHOLM, Aug. 21, 2024 /PRNewswire/ — January 1 – June 30, 2024 The second quarter in figures Net sales were TSEK 6,641 (5,085), +31%. The loss after tax was TSEK 15,050 (11,352). The loss per share was SEK 0.08 (0.16). The cash flow from current operations was negative in the amount…